health

LAVAL, Quebec, March 01, 2022–(BUSINESS WIRE)–BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough (“RCC”) and other cough hypersensitivity indications, today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in a panel at the Cowen & Co. 42^nd Annual Health Care Conference.

Panel Details:
Event: Cowen & Co. 42^nd Annual Health Care Conference
Title: Respiratory/Infections Panel
Date/Time: Tuesday, March 8^th, 2022 at 2:10 p.m. ET

A webcast of the panel discussion may be accessed on the Events & Presentations page under the Investors & Media section of BELLUS Health’s website at www.bellushealth.com. Following the event, an archived webcast will be available on the Company’s website.

About BELLUS Health (www.bellushealth.com)
BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for

Queen Elizabeth recently dropped the news that Prince Charles’ wife Duchess Camilla would become Queen Consort upon his eventual ascension to the throne, and apparently Prince William and Prince Harry were shocked.

Author and royal expert Christopher Andersen tells Us Weekly that the Queen’s decision to approve of Camilla’s Queen Consort title is “driving a wedge” in the royal family, and that when it comes to Wills and Harry, “I can tell you right now that the boys were completely blindsided by this.”

“It’s just whether or not they can get over this bad feeling,” Christopher said. “Then, of course, Queen [Elizabeth II]‘s health and these other considerations are there. I don’t think it helped with the queen announcing that Duchess Camilla will be Queen Consort and that’s another issue.”

According to the author, Prince Charles

“I envision her as the director of public health,” Parson said, “and I’m not looking for anyone else.”

Nickelson’s appointment comes one month after the Republican-led Senate scuttled the nomination of Don Kauerauf as health director amid a backlash from some conservative senators over COVID-19 policies and abortion. Though Kauerauf had served as director since September,